Accès ouvert
2025
article
OpenAlex
Luis Basbus, Maite Queral, Delfina Peralta Tanco, Marta Bonet et autres
PURPOSE In Argentina, anaplastic lymphoma kinase (ALK) gene rearrangements occur in approximately 6.1% of non–small cell lung cancer (NSCLC) cases. Given the availability of second- and third-generation ALK inhibitors, real-world data are needed to inform optimal treatment strategies. However, access to these …
ar, ch
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres
Background/Objectives: The BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression-free survival (PFS) and in the first- and …
ar, fr
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres
Background/Objectives: BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression free survival (PFS) and overall survival (OS) in …
ar, uy
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Pablo Mandó, Federico Waisberg, Rosario Pasquinelli, Sergio Rivero et autres
Around 20% of breast cancers are associated with amplification or overexpression of human epidermal growth factor receptor 2 (HER2). In this setting, anti-HER2-targeted agents are the cornerstone of cancer therapeutic strategies. This includes monoclonal antibodies, tyrosine kinase inhibitors (TKIs) and, recently, antibody-drug …
ar
(code pays fourni par la source)